Join an expert panel of clinicians and scientists as they discuss insights from the Evaluation of Longitudinal Pain Study in Sickle Cell Disease (ELIPSIS), a pivotal study evaluating the relationship of blood-based biomarkers and pain from the patient’s perspective

Patrick Hines, MD/ PhD and Michael Callaghan, MD, discuss:

- How red blood cell health biomarkers can be used to differentiate self-reported healthy state from acute crises state

- How red blood cell health biomarkers can help stratify patients based on their risk of developing self-reported acute pain crises

- How red blood cell health biomarkers can be diagnostic biomarkers of adhesion-associated acute pain crises

info@functionalfluidics.com

(313) 315-2555